Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies

INTRODUCTION: SARS-CoV-2 is a RNA virus that associates with heterogeneous clinical manifestations and complications. Auto-antibodies are identified in approximately 50% of hospitalized COVID-19 patients. OBJECTIVES: To determine the global incidence of myositis-related auto-antibodies (non Jo1-RNA...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Bravo, Laura, Calle-Rubio, Myriam, Fernández-Arquero, Miguel, Mohamed Mohamed, Kauzar, Guerra-Galán, Teresa, Guzmán-Fulgencio, María, Rodríguez de la Peña, Antonia, Cañizares, Cristina, López, Bárbara, Vadillo, Cristina, Matías-Guiu, Jorge, Nieto Barbero, Asunción, Álvarez-Sala Walther, José Luis, Sánchez-Ramón, Silvia, Ochoa-Grullón, Juliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
VSI:Autoantibodies in disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242685/
https://www.ncbi.nlm.nih.gov/pubmed/35789569
http://dx.doi.org/10.1016/j.jtauto.2022.100160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242685/
https://www.ncbi.nlm.nih.gov/pubmed/35789569
http://dx.doi.org/10.1016/j.jtauto.2022.100160

Ejemplares similares